Trials / No Longer Available
No Longer AvailableNCT04644107
Expanded Access for Marizomib
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to Marizomib.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Marizomib | Marizomib will be administered via IV |
Timeline
- First posted
- 2020-11-25
- Last updated
- 2020-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04644107. Inclusion in this directory is not an endorsement.